TP53 and acute myeloid leukemia: APR-245 (p53-mutated protein inhibitor) [17], ATPR (a novel all-trans retinoic acid derivative) [18], FTY720 (sphingosine-1-phosphate inhibitor) [19], typhaneoside [20], and dihydroartemisinin (DHC) [21] can induce ferroptosis in AML cells.